BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

TriLink BioTechnologies Awarded SBIR Phase I Grant


2/28/2013 11:40:12 AM

SAN DIEGO (February 28, 2013) - TriLink BioTechnologies Inc. (TriLink, trilinkbiotech.com) was recently awarded a Phase I SBIR Grant of approximately $130,000 by the National Institutes of Health to develop an approach to RNA sample preparation for Next Generation Sequencing (NGS) using TriLink's expertise in nucleic acid chemistry. This is the sixth Phase I grant TriLink has been awarded and it will be funded through July 2013. TriLink plans to investigate methods to reduce formation of adapter dimers during RNA sample preparation which will remove the need for gel purification prior to sequencing.

"Improving the process of RNA sample preparation for next generation sequencing will increase the accessibility of this valuable tool," commented Richard Hogrefe, CEO of TriLink. "We are pleased to utilize our strengths in the modification of nucleic acids to support the evolution of this technology."

"Next generation sequencing is becoming the mainstay of genomics research," said Dr. Natasha Paul, Principal Investigator on the grant. "We are pleased to contribute to this growing field streamline NGS sample preparation workflows for small RNA deep sequencing."

About TriLink

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, long RNA transcript synthesis and contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 50 scientists and other professionals. For more information about the firm and products, visit our web site at www.trilinkbiotech.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES